1 August 2025 false Taxfiler 2024.6 true 13519036business:PrivateLimitedCompanyLtd2025-08-012026-07-31 135190362025-07-31 135190362025-08-012026-07-31 13519036business:AuditExemptWithAccountantsReport2025-08-012026-07-31 13519036business:FilletedAccounts2025-08-012026-07-31 135190362026-07-31 13519036business:Director12025-08-012026-07-31 13519036business:Director22025-08-012026-07-31 13519036business:RegisteredOffice2025-08-012026-07-31 135190362025-07-31 13519036core:WithinOneYear2026-07-31 13519036core:WithinOneYear2025-07-31 13519036core:ShareCapitalcore:PreviouslyStatedAmount2026-07-31 13519036core:ShareCapitalcore:PreviouslyStatedAmount2025-07-31 13519036core:RetainedEarningsAccumulatedLossescore:PreviouslyStatedAmount2026-07-31 13519036core:RetainedEarningsAccumulatedLossescore:PreviouslyStatedAmount2025-07-31 13519036core:PreviouslyStatedAmount2026-07-31 13519036core:PreviouslyStatedAmount2025-07-31 13519036business:SmallEntities2025-08-012026-07-31 13519036countries:EnglandWales2025-08-012026-07-31 13519036core:MotorVehicles2025-08-012026-07-31 13519036core:ComputerEquipment2025-08-012026-07-31 13519036core:MotorVehicles2025-07-31 13519036core:ComputerEquipment2025-07-31 13519036core:MotorVehicles2026-07-31 13519036core:ComputerEquipment2026-07-31 135190362024-08-012025-07-31 iso4217:GBP xbrli:pure
Company Registration No. 13519036 (England and Wales)
Model Pharm Limited Unaudited accounts for the year ended 31 July 2026
Model Pharm Limited Unaudited accounts Contents
Page
- 2 -
Model Pharm Limited Company Information for the year ended 31 July 2026
Directors
Mr Oladipo Rasheed Sodunke Mr Olagoke Abdulganiu Sodunke
Company Number
13519036 (England and Wales)
Registered Office
6 SAMPHIRE ROAD OXFORD OX4 6RF ENGLAND
Accountants
Edmil Accountants UK Ltd 78A Broadway Didcot Oxfordshire OX11 8AE
- 3 -
Model Pharm Limited Statement of financial position as at 31 July 2026
2026 
2025 
Notes
£ 
£ 
Fixed assets
Tangible assets
2,863 
4,217 
Current assets
Cash at bank and in hand
3,871 
25 
Creditors: amounts falling due within one year
(13,102)
(15,010)
Net current liabilities
(9,231)
(14,985)
Net liabilities
(6,368)
(10,768)
Capital and reserves
Called up share capital
1 
1 
Profit and loss account
(6,369)
(10,769)
Shareholders' funds
(6,368)
(10,768)
For the year ending 31 July 2026 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies. The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with the provisions of FRS 102 Section 1A - Small Entities. The profit and loss account has not been delivered to the Registrar of Companies.
The financial statements were approved by the Board of Directors and authorised for issue on 12 October 2026 and were signed on its behalf by
Mr Oladipo Rasheed Sodunke Director Company Registration No. 13519036
- 4 -
Model Pharm Limited Notes to the Accounts for the year ended 31 July 2026
1
Statutory information
Model Pharm Limited is a private company, limited by shares, registered in England and Wales, registration number 13519036. The registered office is 6 SAMPHIRE ROAD, OXFORD, OX4 6RF, ENGLAND.
2
Compliance with accounting standards
The accounts have been prepared in accordance with the provisions of FRS 102 Section 1A Small Entities. There were no material departures from that standard.
3
Accounting policies
The principal accounting policies adopted in the preparation of the financial statements are set out below and have remained unchanged from the previous year, and also have been consistently applied within the same accounts.
Basis of preparation
The accounts have been prepared under the historical cost convention as modified by the revaluation of certain fixed assets.
Presentation currency
The accounts are presented in £ sterling.
Tangible fixed assets and depreciation
Tangible assets are included at cost less depreciation and impairment. Depreciation has been provided at the following rates in order to write off the assets over their estimated useful lives:
Motor vehicles
25% SLM
Computer equipment
33.33 % SLM
Going concern
The directors believe that the company is experiencing good levels of sales growth and profitability, and that it is well placed to manage its business risks successfully. Accordingly, they have a reasonable expectation that the company has adequate resources to continue in operational existence for the foreseeable future. Thus they continue to adopt the going concern basis of accounting in preparing the financial statements.
4
Tangible fixed assets
Motor vehicles 
Computer equipment 
Total 
£ 
£ 
£ 
Cost or valuation
At cost 
At cost 
At 1 August 2025
3,999 
1,062 
5,061 
At 31 July 2026
3,999 
1,062 
5,061 
Depreciation
At 1 August 2025
667 
177 
844 
Charge for the year
1,000 
354 
1,354 
At 31 July 2026
1,667 
531 
2,198 
Net book value
At 31 July 2026
2,332 
531 
2,863 
At 31 July 2025
3,332 
885 
4,217 
- 5 -
Model Pharm Limited Notes to the Accounts for the year ended 31 July 2026
5
Creditors: amounts falling due within one year
2026 
2025 
£ 
£ 
Bank loans and overdrafts
1,876 
637 
Other creditors
5,959 
2,280 
Loans from directors
4,617 
11,443 
Accruals
650 
650 
13,102 
15,010 
6
Transactions with related parties
At year end, the Company owed the sum of £4,617 (FY:2025 - £11,443) to the Director Mr Oladipo Rasheed Sodunke.
7
Average number of employees
During the year the average number of employees was 2 (2025: 2).
- 6 -